Solid biosciences to participate in chardan's 7th annual genetic medicines and cell therapy manufacturing summit

Charlestown, mass., april 21, 2023 (globe newswire) -- solid biosciences inc. (nasdaq: sldb), a life sciences company developing genetic medicines for neuromuscular and cardiac diseases, today announced that solid management will participate in a fireside chat at chardan's 7th annual genetic medicines and cell therapy manufacturing summit on monday, april 24, 2023 at 2:00 pm et.
SLDB Ratings Summary
SLDB Quant Ranking